New Generation of Clinical Epigenetics Analysis and Diagnosis for Precision Medicine
Open accessThe DOI matches its Crossref record; 76 of the 77 references it cites were found in a registry or an index.
Abstract
Following the application of epigenetic and epigenomics research into tumor diseases, cardiovascular disease, diabetes, hereditary diseases, and rare diseases, in vitro diagnostics (IVD) epigenetic and epigenomics are increasingly employed for those patients. Here, we review a clinical sampling of epigenetics and epigenomics from patients. We then present procedures, including the detection procedure of clinical epigenetic approaches from clinical samples, clinical epigenomic methods applied to those samples, the small cell number of epigenetics, and epigenomics. Finally, we present the current IVD of epigenetics and epigenomics used for clinical analysis and diagnosis, along with the development of approaches. To improve clinical study and diagnosis, we also introduce clinical research and clinical applications to develop a more comprehensive strategy to maximize the sensitivity and specificity of the epigenetics and epigenomics analysis and diagnosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Landscape of transcription in human cells
Djebali, S., Davis, C. A., Merkel, A., Dobin, A., Lassmann, T., Mortazavi, A., Tanzer, A., Lagarde, J., Lin, W., Schlesinger, F., et al. (2012) · Nature · doi:10.1038/nature11233 · Cited by 5,187 · cited 1×
“Clinical studies have find that lncRNAs are related to metabolism and immunity diseases and are closely related to the occurrence and development of tumors, CVD, nervous system disorders, and nephropathy [19,20].”
Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAs
Rinn, J. L., Kertesz, M., Wang, J. K., Squazzo, S. L., Xu, X., Brugmann, S. A., Goodnough, L. H., Helms, J. A., Farnham, P. J., Segal, E., et al. (2007) · Cell · doi:10.1016/j.cell.2007.05.022 · Cited by 4,244
Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
Motzer, R. J., Penkov, K., Haanen, J., Rini, B., Albiges, L., Campbell, M. T., Venugopal, B., Kollmannsberger, C., Negrier, S., Uemura, M., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1816047 · Cited by 2,503
HDAC6 is a microtubule-associated deacetylase
Hubbert, C., Guardiola, A., Shao, R., Kawaguchi, Y., Ito, A., Nixon, A., Yoshida, M., Wang, X.-F., & Yao, T.-P. (2002) · Nature · doi:10.1038/417455a · Cited by 2,403 · cited 1×
“…Non-Repressible 5 (GNC5), CREB-binding protein (CBP), P300/CBP-binding protein (PCAF), MYST family, P300, TAFII250, and Rtt109 are increasingly reported in histone modification, which can increase clinical epigenetics analysis and diagnosis to increase epigenetics therapeutic potential [67–74].”
Modification of Enhancer Chromatin: What, How, and Why?
Calo, E., & Wysocka, J. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.038 · Cited by 1,457
Stine, Z. E., Walton, Z. E., Altman, B. J., Hsieh, A. L., & Dang, C. V. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0507 · Cited by 1,375
The functions and unique features of long intergenic non-coding RNA
Ransohoff, J. D., Wei, Y., & Khavari, P. A. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.104 · Cited by 1,330
Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy
Peng, D., Kryczek, I., Nagarsheth, N., Zhao, L., Wei, S., Wang, W., Sun, Y., Zhao, E., Vatan, L., Szeliga, W., et al. (2015) · Nature · doi:10.1038/nature15520 · Cited by 1,201
Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer
Asangani, I. A., Dommeti, V. L., Wang, X., Malik, R., Cieslik, M., Yang, R., Escara-Wilke, J., Wilder-Romans, K., Dhanireddy, S., Engelke, C., et al. (2014) · Nature · doi:10.1038/nature13229 · Cited by 927
Pal, S., & Tyler, J. K. (2016) · Science Advances · doi:10.1126/sciadv.1600584 · Cited by 860
Cited by
Epigenetic regulation of circulating tumor cells in precision oncology
Farah, H. S., Abosaoda, M. K., Mousa, H. M., Renuka Jyothi, S., Nayak, P. P., Janney, J. B., Singh, G., & Chauhan, A. S. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156282 · Cited by 3
Kac, E., Qi, Q., & Ryznar, R. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1769422 · Cited by 1
An epigenetic perspective on neonatal encephalopathy with suspected hypoxic ischaemic encephalopathy
Mistry, P., Mellet, J., Durandt, C., Smuts, I., & Pepper, M. S. (2025) · Clinical Epigenetics · doi:10.1186/s13148-025-01984-z · Cited by 1
Manso, J., Sardone, D., Marotta, V., Salcuni, A. S., Brunetti, A., Cipri, C., Sciannimanico, S. M., Piva, L., Carpentieri, M. S., Falchetti, A., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27021116
Epigenetics and Health Inequities in Indigenous, Black, and Hispanic Communities
Shi, K. (2026) · Scholarly review . · doi:10.70121/001c.163222
Metadata
- Authors
- Song, P., & Li, B.
- Affiliations
- Zhejiang Chinese Medical University (CN)
- School of Medicine, Case Western Reserve University, 10900 Euclid Ave, Cleveland, OH 44106, USA
- Venue
- Diagnostics
- Publisher
- MDPI AG
- Published
- 2025-06-17
- Volume
- 15
- Issue
- 12
- Pages
- 1539
- ISSN
- 2075-4418 (ISSN-L)
- PMC
- PMC12192280
- OpenAlex
- W4411377817
- Cited by
- 4
- References
- 77
- Citations by year
- 2026: 3 · 2025: 1
- FWCI
- 0.35
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Diagnostics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- in vitro diagnostics, precision medicine, epigenetic biomarkers, epigenomic biomarkers, clinical sample analysis, sensitivity and specificity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: New Generation of Clinical Epigenetics Analysis and Diagnosis for Precision Medicine. https://app.cochat.ai/papers/10.3390/diagnostics15121539
- The paper
- Song, P., & Li, B. (2025). New Generation of Clinical Epigenetics Analysis and Diagnosis for Precision Medicine. Diagnostics. https://doi.org/10.3390/diagnostics15121539
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.